+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 4.340 HKD | -0.238 | -5.199% | 221.06M | 976.61M | 4.401 (-1.377%) HKD as at 2025/01/20 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 2.990 HKD | +0.148 | +5.208% | 177.84M | 523.39M | 2.971 (+0.650%) HKD as at 2025/01/20 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 3.742 HKD | +0.138 | +3.829% | 81.92M | 303.59M | 3.681 (+1.668%) HKD as at 2025/01/20 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 3.738 HKD | -0.148 | -3.809% | 57.72M | 217.74M | 3.813 (-1.972%) HKD as at 2025/01/20 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 4.778 HKD | -0.096 | -1.970% | 2.83M | 13.53M | 4.891 (-2.312%) HKD as at 2025/01/17 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 2.370 HKD | -0.102 | -4.126% | 3.98M | 9.55M | 2.418 (-1.977%) HKD as at 2025/01/20 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 12.450 HKD | +0.170 | +1.384% | 760.20K | 9.47M | 12.319 (+1.063%) HKD as at 2025/01/17 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 3.674 HKD | -0.066 | -1.765% | 1.85M | 6.83M | 3.530 (+4.082%) HKD as at 2025/01/17 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng China Enterprises | 2.880 HKD | +0.122 | +4.423% | 2.10M | 5.92M | 2.836 (+1.569%) HKD as at 2025/01/20 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 4.784 HKD | +0.088 | +1.874% | 828.60K | 3.93M | 4.743 (+0.871%) HKD as at 2025/01/20 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 3.508 HKD | -0.078 | -2.175% | 953.20K | 3.36M | 3.580 (-1.997%) HKD as at 2025/01/20 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 0.723 HKD | -0.015 | -2.033% | 4.01M | 2.91M | 0.741 (-2.482%) HKD as at 2025/01/17 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | NASDAQ-100 Index | 26.760 HKD | +0.560 | +2.137% | 96.80K | 2.58M | 26.135 (+2.391%) HKD as at 2025/01/17 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Nikkei Stock Average Index | 60.600 HKD | -1.900 | -3.040% | 17.45K | 1.06M | 62.742 (-3.414%) HKD as at 2025/01/20 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | S&P Bitcoin Futures Index | 4.470 HKD | -0.176 | -3.788% | 132.10K | 591.48K | 4.503 (-0.724%) HKD as at 2025/01/17 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | NASDAQ-100 Index | 35.220 HKD | +0.740 | +2.146% | 13.80K | 485.76K | 34.389 (+2.417%) HKD as at 2025/01/17 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Nikkei Stock Average Index | 76.000 HKD | +2.260 | +3.065% | 560.00 | 42.58K | 73.264 (+3.734%) HKD as at 2025/01/20 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | FTSE Taiwan RIC Capped Index | 4.364 HKD | -0.022 | -0.502% | 0.00 | 0.00 | 0.570 (-1.771%) USD as at 2025/01/17 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | FTSE Taiwan RIC Capped Index | 13.750 HKD | +0.230 | +1.701% | 0.00 | 0.00 | 1.706 (+3.474%) USD as at 2025/01/17 | | |